Last reviewed · How we verify

NCT03385915: FinnValve

Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis: FinnValve Registry

Completed Last updated 10 March 2020
What this trial tests

trial testing Aortic valve replacement in Aortic Valve Stenosis in 6,463 participants. Completed in 9 March 2020.

Timeline
1 December 2017
Primary endpoint
9 March 2020
9 March 2020

Quick facts

Lead sponsorTurku University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,463
Start date1 December 2017
Primary completion9 March 2020
Estimated completion9 March 2020
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Turku University Hospital

Who can join

18 and older, any sex, with Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The FinnValve investigators planned a nationwide registry to investigate the early and late outcome of transcatheter aortic valve implantation (TAVI) compared to surgical aortic valve replacement (SAVR) in patients with aortic valve stenosis performed from 2008 to 2017 at five Finnish University Hospitals. Data will be collected in a dedicated electronic case report form.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement.
    Laakso T, Laine M, Moriyama N, Dahlbacka S, et al · · 2020 · cited 56× · PMID 33057657 · DOI 10.1093/ejcts/ezaa254
  2. Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve Registry.
    Moriyama N, Laakso T, Biancari F, Raivio P, et al · · 2019 · cited 54× · PMID 31113766 · DOI 10.4244/eij-d-19-00247
  3. Comparison of Outcomes After Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement Among Patients With Aortic Stenosis at Low Operative Risk.
    Virtanen MPO, Eskola M, Jalava MP, Husso A, et al · · 2019 · cited 38× · PMID 31199448 · DOI 10.1001/jamanetworkopen.2019.5742
  4. Transcatheter and surgical aortic valve replacement in patients with bicuspid aortic valve.
    Husso A, Airaksinen J, Juvonen T, Laine M, et al · · 2021 · cited 27× · PMID 33099681 · DOI 10.1007/s00392-020-01761-3
  5. Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement.
    Biancari F, Dahlbacka S, Juvonen T, Virtanen MPO, et al · · 2020 · cited 19× · PMID 32216975 · DOI 10.1016/j.ijcard.2020.03.038
  6. Impact of Major Vascular Complication Access Site Status on Mortality After Transfemoral Transcatheter Aortic Valve Replacement - Results From the FinnValve Registry.
    Laakso T, Moriyama N, Raivio P, Dahlbacka S, et al · · 2020 · cited 11× · PMID 33693226 · DOI 10.1253/circrep.cr-20-0007
  7. Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.
    Mäkikallio T, Jalava MP, Husso A, Virtanen M, et al · · 2019 · cited 11× · PMID 31112060 · DOI 10.1080/07853890.2019.1614657
  8. Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    Jaakkola J, Jaakkola S, Airaksinen KEJ, Husso A, et al · · 2020 · cited 5× · PMID 32915895 · DOI 10.1371/journal.pone.0238953

Verify or expand the search:

Other trials of Aortic valve replacement

Trials testing the same drug.

Other recruiting trials for Aortic Valve Stenosis

Currently open trials in the same condition.

Other Turku University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03385915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing